Evidence map›Paper›PMID 17977998›Full record

ArticleJournal of clinical microbiology2008

Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles.

Janeen R Shepard, Rachel M Addison, Barbara D Alexander, Phyllis Della-Latta, Michael Gherna, Gerhard Haase, Gerri Hall, Jennifer K Johnson, William G Merz, Heidrun Peltroche-Llacsahuanga and 6 more

Open access · greenAbstract readEvaluation StudyMulticenter Study
In one paragraph

Article in Journal of clinical microbiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Identification ofJournal of fungi (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Molecular diagnosis of sepsis: New aspects and recent developments.European journal of microbiology & immunology · 2014
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Janeen R ShepardAdvanDx, Inc., 10A Roessler Road, Woburn, MA 01801, USA.
Rachel M Addison
Barbara D Alexander
Phyllis Della-Latta
Michael Gherna
Gerhard Haase
Gerri Hall
Jennifer K Johnson
William G Merz
Heidrun Peltroche-Llacsahuanga
Henrik Stender
Richard A Venezia
Deborah Wilson
Gary W Procop
Fann Wu
Mark J Fiandaca
Cleveland Clinic · USColumbia University Irving Medical Center · USDuke Medical Center · USJohns Hopkins University · USRWTH Aachen University · DEUniversity of Maryland, Baltimore · USUniversity of Maryland Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the performance of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization (PNA FISH) method, a rapid two-color assay for detection of C. albicans and C. glabrata, in a multicenter study. The assay is designed for use directly from positive blood culture bottles in a FISH format. Intact, fixed cells are labeled fluorescent green (C. albicans) or fluorescent red (C. glabrata) by rRNA hybridization of fluorophore-labeled PNA probes. Results are available <3 h after cultures signal positive. An evaluation of 197 routine blood culture bottles newly positive for yeast by Gram staining was performed at five hospitals. The sensitivities of detection for C. albicans, and C. glabrata were 98.7% (78/79) and 100% (37/37), respectively, and the specificity for both components of the assay was 100% (82/82). The assay was also evaluated with 70 fungal reference strains and was challenged in the BacT/ALERT microbiological detection system with spiked blood culture bottles. These results support the use of the assay for rapid, simultaneous identification of C. albicans and C. glabrata in positive blood culture bottles. This rapid assay may aid in the selection of initial antifungal drugs, leading to improved patient outcomes.

Indexed as

Peptide Nucleic AcidsBloodCandida albicansCandida glabrataCandidiasisHumansIn Situ Hybridization, FluorescenceSensitivity and SpecificityPeptide Nucleic Acids

Identifiers

PMID17977998
PMCPMC2224311
OpenAlexW2129515144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.